Artwork

Emma Nichols, PhD and Emma Hitt Nichols에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Emma Nichols, PhD and Emma Hitt Nichols 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!

Leqembi, Aveir Pacemaker, Cyclophosphamide Liquid, IPX203

7:16
 
공유
 

Manage episode 407556916 series 3561458
Emma Nichols, PhD and Emma Hitt Nichols에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Emma Nichols, PhD and Emma Hitt Nichols 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Get our free download! Implementing AMA Style – 8 Things to Get Right Here are the highlights of this week's episode:

· The FDA granted traditional approval to Leqembi, an Alzheimer's treatment manufactured by Eisai and Biogen. The approval, based on phase 3 data demonstrating reduced cognitive decline in early Alzheimer's patients, makes Leqembi the first approved drug in its class, offering new treatment possibilities for the 6.5 million Alzheimer's patients in the US.

· Abbott's Aveir™ DR Dual Chamber Leadless Pacemaker is the first dual chamber leadless pacemaker system for individuals with abnormal or slow heart rhythms. Utilizing the body's natural conductive properties, the device offers more efficient battery usage compared to other communication technologies and reduces the risk of complications associated with traditional pacemakers due to its minimally invasive implantation procedure.

· The FDA approved a liquid formulation of the cancer drug cyclophosphamide. The new formulation, manufactured by Nevakar, is available in two doses and offers advantages over current powdered forms, including increased stability and reduced risk of dosing errors.

· Amneal Pharmaceuticals received a Complete Response Letter from the FDA regarding IPX203 for Parkinson's disease. While this extended-release formation of carbidopa/levodopa shows promise with more effective therapeutic benefits than current formulations, the FDA requested additional safety information on a component of the drug, carbidopa. Amneal will continue working with the FDA to address its concerns.

Please check back every Monday morning for last week's approvals so that you can stay up to date.

Visit our podcast page here.

This podcast is brought to you by Nascent Medical. If you're a project manager at a CME or medical communications agency and need on-call medical writing assistance please visit Nascent Medical. We are a team of MD- and PhD-level medical writers and can create slide decks, white papers, ad board summaries, manuscripts, needs assessments, and much more. We also do medical editing using AMA style and factchecking. Visit nascentmc.com

Intro and outro music

Garden Of Love by Pk jazz Collective

  continue reading

49 에피소드

Artwork
icon공유
 
Manage episode 407556916 series 3561458
Emma Nichols, PhD and Emma Hitt Nichols에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Emma Nichols, PhD and Emma Hitt Nichols 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Get our free download! Implementing AMA Style – 8 Things to Get Right Here are the highlights of this week's episode:

· The FDA granted traditional approval to Leqembi, an Alzheimer's treatment manufactured by Eisai and Biogen. The approval, based on phase 3 data demonstrating reduced cognitive decline in early Alzheimer's patients, makes Leqembi the first approved drug in its class, offering new treatment possibilities for the 6.5 million Alzheimer's patients in the US.

· Abbott's Aveir™ DR Dual Chamber Leadless Pacemaker is the first dual chamber leadless pacemaker system for individuals with abnormal or slow heart rhythms. Utilizing the body's natural conductive properties, the device offers more efficient battery usage compared to other communication technologies and reduces the risk of complications associated with traditional pacemakers due to its minimally invasive implantation procedure.

· The FDA approved a liquid formulation of the cancer drug cyclophosphamide. The new formulation, manufactured by Nevakar, is available in two doses and offers advantages over current powdered forms, including increased stability and reduced risk of dosing errors.

· Amneal Pharmaceuticals received a Complete Response Letter from the FDA regarding IPX203 for Parkinson's disease. While this extended-release formation of carbidopa/levodopa shows promise with more effective therapeutic benefits than current formulations, the FDA requested additional safety information on a component of the drug, carbidopa. Amneal will continue working with the FDA to address its concerns.

Please check back every Monday morning for last week's approvals so that you can stay up to date.

Visit our podcast page here.

This podcast is brought to you by Nascent Medical. If you're a project manager at a CME or medical communications agency and need on-call medical writing assistance please visit Nascent Medical. We are a team of MD- and PhD-level medical writers and can create slide decks, white papers, ad board summaries, manuscripts, needs assessments, and much more. We also do medical editing using AMA style and factchecking. Visit nascentmc.com

Intro and outro music

Garden Of Love by Pk jazz Collective

  continue reading

49 에피소드

모든 에피소드

×
 
Loading …

플레이어 FM에 오신것을 환영합니다!

플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.

 

빠른 참조 가이드